Skip to main content
AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.908
-0.082 (-8.32%)
Feb 27, 2026, 4:00 PM EST - Market closed

AIM ImmunoTech Revenue

AIM ImmunoTech had revenue of $26.00K in the quarter ending September 30, 2025, a decrease of -25.71%. This brings the company's revenue in the last twelve months to $112.00K, down -41.05% year-over-year. In the year 2024, AIM ImmunoTech had annual revenue of $170.00K, down -15.84%.

Revenue (ttm)
$112.00K
Revenue Growth
-41.05%
P/S Ratio
34.20
Revenue / Employee
$4,870
Employees
23
Market Cap
3.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024170.00K-32.00K-15.84%
Dec 31, 2023202.00K61.00K43.26%
Dec 31, 2022141.00K6.00K4.44%
Dec 31, 2021135.00K-28.00K-17.18%
Dec 31, 2020163.00K23.00K16.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CASI Pharmaceuticals 26.85M
Jaguar Health 11.79M
GeoVax Labs 3.35M
60 Degrees Pharmaceuticals 1.36M
PMGC Holdings 285.95K
Revenue Rankings

AIM News

More News